ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO HAVE GENOTYPE 3, CIRRHOSIS, ARE INTERFERON-INELIGIBLE/INTOLERANT, OR HAVE FAILED PREVIOUS THERAPY"
Episode Synopsis
Special Edition 2014, Issue 1, Part 2.Mark S. Sulkowski, MD from Johns Hopkins University School of Medicine in Baltimore discusses patients who have genotype 3 or cirrhosis, are interferon-ineligible/intolerant, or have failed previous therapy with program director, Dr. Raymond Chung.The post INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO HAVE GENOTYPE 3, CIRRHOSIS, ARE INTERFERON-INELIGIBLE/INTOLERANT, OR HAVE FAILED PREVIOUS THERAPY appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.
More episodes of the podcast eViralHepatitis Review
Medications for CHB
20/10/2022
To Treat or Not To Treat
20/10/2022
HBV & Coinfections
20/10/2022
Hepatitis B: Our Current Understanding
20/10/2022
HBV: Next Steps to a Cure
03/08/2021
Treating HCV in PWID: Best Practices
10/04/2020
HCV: Management Beyond the Liver
04/03/2020
Avoiding “MELD Purgatory”
19/04/2019
Clinical Insight: Engaging PWID in HCV Care
28/12/2018
In God we trust